The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring expression levels of HER2, HER3, MET, Claudin18.2, and MUC16 across 16 cancer types using an artificial intelligence-powered immunohistochemistry analyzer.
 
Seunghwan Shin
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Soo Ick Cho
Employment - Lunit
Stock and Other Ownership Interests - Lunit
Consulting or Advisory Role - ArtLab
 
Sangjoon Choi
No Relationships to Disclose
 
Taebum Lee
No Relationships to Disclose
 
Seulki Kim
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Wonkyung Jung
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Mohammad Mostafavi
Employment - Lunit
 
Biagio Brattoli
Employment - Lunit
 
Jeongun Ryu
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Seonwook Park
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Sergio Pereira
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Ken Nesmith
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit
 
Jiyoung Park
Employment - Lunit
Stock and Other Ownership Interests - lunit
 
Melody SeungHui Seo
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Huijeong Kim
Employment - Lunit
Stock and Other Ownership Interests - Lunit
 
Seokhwi Kim
No Relationships to Disclose
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Medpacto; Y-Biologics
Consulting or Advisory Role - Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics